Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENOIC ACID for Cardiac failure: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where CANRENOIC ACID was used for Cardiac failure.

Most Reported Side Effects for CANRENOIC ACID

Side Effect Reports % Deaths Hosp.
Hyperkalaemia 33 23.6% 0 29
Toxic epidermal necrolysis 33 23.6% 8 0
Drug hypersensitivity 24 17.1% 0 0
Off label use 24 17.1% 0 0
Product use in unapproved indication 20 14.3% 0 0
Asthenia 16 11.4% 0 9
Hyponatraemia 14 10.0% 0 13
Epistaxis 13 9.3% 0 13
Dehydration 11 7.9% 0 10
Acute kidney injury 10 7.1% 0 8
Hypotension 10 7.1% 0 8
International normalised ratio increased 10 7.1% 0 10
Bradycardia 9 6.4% 0 9
Syncope 9 6.4% 0 7
Dyspnoea 8 5.7% 0 4

Other Indications for CANRENOIC ACID

Hypertension (57) Product used for unknown indication (25) Ill-defined disorder (21) Renal impairment (7) Acute coronary syndrome (5)

Other Drugs Used for Cardiac failure

SACUBITRIL\VALSARTAN (24,514) FUROSEMIDE (3,772) SPIRONOLACTONE (1,622) BISOPROLOL (1,344) EMPAGLIFLOZIN (1,338) DAPAGLIFLOZIN (1,332) RAMIPRIL (726) TOLVAPTAN (601) CARVEDILOL (596) METOPROLOL (536)

Related Pages

CANRENOIC ACID Full Profile All Cardiac failure Drugs CANRENOIC ACID Demographics CANRENOIC ACID Timeline